As lymphocytic tumours go, those involving the orbit are rare, accounting for just over 2% of one large series reported from a general oncology unit, and even fewer appear in the orbit as a primary event. ' The development of lymphoid lesions in this situation is presumed to be due to either neoplasia or reactive hyperplasia. The former is amenable to low-dosage radiotherapy, whereas the latter may sometimes be combated by the administration of corticosteroids on the assumption that it is an inflammatory response, albeit to an unknown antigen. In that case it is of more than academic interest to be able to distinguish between them.
In recent years there has been an attempt, attributable in particular to Jakobiec and his coworkers, to make the distinction on immunological grounds. That the attempt has not been entirely successful has not been through any inadequacy of the methods employed but There has been some speculation on why orbital lymphomas tend to be confined to the orbit for long periods before metastasising. One possibility is that they are initially reactive lesions and only subsequently become truly neoplastic,'5 while another is that they share a feature common to several other types of extranodal lymphomas of homing back to their tissue of origin should they enter the general circulation.2 The absence of lymphatic drainage channels might also impede dissemination.
INDETERMINATE LYMPHOID PROLIFERATIONS
There are some lymphocytic lesions within the orbit that defy ready categorisation. They may present as masses of mainly small mature lymphocytes with few, if any, of the atypical forms which would point to neoplasia. Or they may lack the mixed leucocyte composition and germinal centre formation indicative ofa reactive process. In those cases where immunohistochemistry serves to demonstrate light chain restriction a diagnosis oflymphoma, usually of low grade malignancy, can be established.'0 The real difficulty arises when there is either absence of immunolabelling by light chain antibodies or, alternatively, a polyclonal pattern.
Failure to respond to immunostaining may be for technical reasons, due to a paucity of reactive groups on the lymphocytes or, conceivably, to the lesion in question being a T cell lymphoma. As yet, however, the only substantiated report of a T cell lymphoma arising within the orbit has concerned a patient in the advanced stages of an HTLV-1 related T cell leukaemia.'6 A polyclonal immunoglobulin profile taken at face value might suggest a reactive process, but clinical experience shows that many patients with this type of lesion later present evidence of dissemination and are seen to be suffering from a true lymphoma.'4"'l7 That a lymphoma should be masked in this way is understandable ifit is allowed that a neoplastic proliferation may supervene in an initially reactive disorder, in which case the two processes would be operating together for a time. Examples of a sequence of this sort have been provided in respect of extranodal lymphomas in other situations, including the bronchus'8 and salivary glands,'9 and there is now good reason to believe that the same is true of the orbit. Indeed, a recent prospective analysis of some 69 patients with orbital lymphoproliferative disease casts serious doubt on the value of making a distinction between neoplastic and putative hyperplastic lesions on the basis that, while 33% of histologically diagnosed lymphomas were associated at some stage with disseminated tumour deposits, as many as 27% of hyperplastic lesions behaved in a similar fashion. ' MANAGEMENT This is not the place for a detailed discussion of therapeutic strategy, but the information which is now available does call for some comment. Since there would seem to be cause to regard all lymphoid proliferations as potential, if not always actual, neoplastic conditions, it is probably sensible to treat all but the most obviously inflammatory lesions accordingly. The response to low doses of radiotherapy, of the order of 30 gray, has been shown to be an effective way of dissipating the apparently indeterminate lymphoid lesions as well as the undoubted lymphomas2" and is much to be preferred to a trial course of corticosteroids given in the hope that the proliferation will prove to be inflammatory. Even so, a note of caution is appropriate, given that a minority of patients can be expected to have occult extraorbital tumour deposits which will only later become clinically manifest. Consequently, a thorough systemic investigation of every patient with an orbital lymphoproliferative mass would seem advisable. 
